AMICUS THERAPEUTICS INC (FOLD)

US03152W1099 - Common Stock

10.54  -0.17 (-1.59%)

After market: 10.54 0 (0%)

Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to FOLD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 19.13. This target is 81.45% above the current price.
FOLD was analyzed by 17 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about FOLD.
In the previous month the buy percentage consensus was at a similar level.
FOLD was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 10.5414.1420.4019.1323.10 - 34.16% 93.55% 81.45% 119.17%
Up and Down Grades
Date Firm Action Rating
2024-03-18 JP Morgan Maintains Overweight -> Overweight
2024-02-29 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-12-19 Morgan Stanley Upgrade Equal-Weight -> Overweight
2023-11-09 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-10-10 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-09-29 JP Morgan Maintains Overweight -> Overweight
2023-07-11 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-03-28 B of A Securities Maintains Buy
2023-03-02 UBS Maintains Buy
2023-03-02 Goldman Sachs Maintains Neutral
2023-01-18 BTIG Maintains Buy
2022-11-08 Morgan Stanley Maintains Equal-Weight
2022-09-09 Morgan Stanley Initiate Equal-Weight
2022-02-24 SVB Leerink Maintains Outperform
2022-01-14 SVB Leerink Upgrade Market Perform -> Outperform
2022-01-13 Cantor Fitzgerald Maintains Overweight
2021-11-15 Stifel Upgrade Hold -> Buy
2021-09-30 SVB Leerink Maintains Market Perform
2021-09-30 JP Morgan Upgrade Neutral -> Overweight
2021-05-27 Needham Initiate Hold
2021-05-21 UBS Initiate Buy
2021-04-14 Cantor Fitzgerald Upgrade Neutral -> Overweight
2021-03-22 SVB Leerink Maintains Market Perform
2021-03-02 Stifel Initiate Hold
2021-02-12 Cantor Fitzgerald Downgrade Overweight -> Neutral
2021-02-12 SVB Leerink Downgrade Outperform -> Market Perform
2021-02-12 JP Morgan Downgrade Overweight -> Neutral